GB1063365A - Improvements relating to derivatives of adamantane - Google Patents
Improvements relating to derivatives of adamantaneInfo
- Publication number
- GB1063365A GB1063365A GB11633/64A GB1163364A GB1063365A GB 1063365 A GB1063365 A GB 1063365A GB 11633/64 A GB11633/64 A GB 11633/64A GB 1163364 A GB1163364 A GB 1163364A GB 1063365 A GB1063365 A GB 1063365A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- adamantane
- cycloalkyl
- formula
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical class C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 229930182555 Penicillin Natural products 0.000 abstract 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 125000004981 cycloalkylmethyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000007522 mineralic acids Chemical class 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 2
- 230000003000 nontoxic effect Effects 0.000 abstract 2
- 150000007524 organic acids Chemical class 0.000 abstract 2
- 229940049954 penicillin Drugs 0.000 abstract 2
- VQHPRVYDKRESCL-UHFFFAOYSA-N 1-bromoadamantane Chemical compound C1C(C2)CC3CC2CC1(Br)C3 VQHPRVYDKRESCL-UHFFFAOYSA-N 0.000 abstract 1
- JACSSWDJQLXNOO-UHFFFAOYSA-N 4-[(2-chlorophenyl)methyl]-5-oxo-4-phenylhexanoic acid Chemical compound C=1C=CC=CC=1C(CCC(O)=O)(C(=O)C)CC1=CC=CC=C1Cl JACSSWDJQLXNOO-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910010084 LiAlH4 Inorganic materials 0.000 abstract 1
- UYBYMWLLFLYVCE-UHFFFAOYSA-N N-(1-adamantyl)-4-methylhex-3-enamide Chemical compound CC(=CCC(=O)NC12CC3CC(CC(C1)C3)C2)CC UYBYMWLLFLYVCE-UHFFFAOYSA-N 0.000 abstract 1
- WRAGCBBWIYQMRF-UHFFFAOYSA-N N-Cyclohexylacetamide Chemical compound CC(=O)NC1CCCCC1 WRAGCBBWIYQMRF-UHFFFAOYSA-N 0.000 abstract 1
- JKNZUZCGFROMAZ-UHFFFAOYSA-L [Ag+2].[O-]S([O-])(=O)=O Chemical compound [Ag+2].[O-]S([O-])(=O)=O JKNZUZCGFROMAZ-UHFFFAOYSA-L 0.000 abstract 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000003925 fat Substances 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000012280 lithium aluminium hydride Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13415761A | 1961-08-28 | 1961-08-28 | |
| US31807363A | 1963-10-22 | 1963-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1063365A true GB1063365A (en) | 1967-03-30 |
Family
ID=26832027
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB11633/64A Expired GB1063365A (en) | 1961-08-28 | 1964-03-19 | Improvements relating to derivatives of adamantane |
| GB21842/66A Expired GB1063366A (en) | 1961-08-28 | 1964-03-19 | Improvements relating to derivatives of adamantane |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB21842/66A Expired GB1063366A (en) | 1961-08-28 | 1964-03-19 | Improvements relating to derivatives of adamantane |
Country Status (10)
| Country | Link |
|---|---|
| BR (1) | BR6457700D0 (enrdf_load_stackoverflow) |
| DE (2) | DE1793384A1 (enrdf_load_stackoverflow) |
| DK (1) | DK127595B (enrdf_load_stackoverflow) |
| FI (1) | FI42207B (enrdf_load_stackoverflow) |
| FR (1) | FR1559564A (enrdf_load_stackoverflow) |
| GB (2) | GB1063365A (enrdf_load_stackoverflow) |
| LU (1) | LU45675A1 (enrdf_load_stackoverflow) |
| NL (1) | NL6403294A (enrdf_load_stackoverflow) |
| NO (1) | NO121269B (enrdf_load_stackoverflow) |
| SE (1) | SE321923B (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5576355A (en) * | 1993-06-04 | 1996-11-19 | Mobil Oil Corp. | Diamondoid derivatives for pharmaceutical use |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20090186A2 (hr) | 2009-03-31 | 2010-10-31 | Institut Ruđer Bošković | Adamantanski bisureidni derivati, metoda priprave i primjena u detekciji aniona |
-
1964
- 1964-03-14 NO NO152434A patent/NO121269B/no unknown
- 1964-03-17 LU LU45675D patent/LU45675A1/xx unknown
- 1964-03-18 BR BR157700/64A patent/BR6457700D0/pt unknown
- 1964-03-19 GB GB11633/64A patent/GB1063365A/en not_active Expired
- 1964-03-19 GB GB21842/66A patent/GB1063366A/en not_active Expired
- 1964-03-20 SE SE3521/64A patent/SE321923B/xx unknown
- 1964-03-24 DK DK149864AA patent/DK127595B/da unknown
- 1964-03-25 FI FI0647/64A patent/FI42207B/fi active
- 1964-03-26 NL NL6403294A patent/NL6403294A/xx unknown
- 1964-03-28 DE DE19641793384 patent/DE1793384A1/de active Pending
- 1964-03-28 DE DE19641468756 patent/DE1468756B2/de active Granted
- 1964-04-13 FR FR1559564D patent/FR1559564A/fr not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5576355A (en) * | 1993-06-04 | 1996-11-19 | Mobil Oil Corp. | Diamondoid derivatives for pharmaceutical use |
Also Published As
| Publication number | Publication date |
|---|---|
| LU45675A1 (enrdf_load_stackoverflow) | 1964-06-15 |
| NO121269B (enrdf_load_stackoverflow) | 1971-02-08 |
| BR6457700D0 (pt) | 1973-07-17 |
| DE1793384A1 (de) | 1972-02-03 |
| DE1468756C3 (enrdf_load_stackoverflow) | 1974-02-14 |
| SE321923B (enrdf_load_stackoverflow) | 1970-03-23 |
| FI42207B (enrdf_load_stackoverflow) | 1970-03-02 |
| DK127595B (da) | 1973-12-03 |
| FR1559564A (enrdf_load_stackoverflow) | 1969-03-14 |
| GB1063366A (en) | 1967-03-30 |
| DE1468756A1 (de) | 1969-08-07 |
| DE1468756B2 (de) | 1973-07-05 |
| NL6403294A (enrdf_load_stackoverflow) | 1965-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
| GB1069069A (en) | An aminoalkylethanoanthracene and process for its manufacture | |
| GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
| GB1429144A (en) | Pharmaceutical compositions | |
| GB1063365A (en) | Improvements relating to derivatives of adamantane | |
| GB862721A (en) | Dialkylaminoethyl derivatives of salicylamides | |
| ES8602654A1 (es) | Procedimiento para la obtencion de nuevos derivados de la piperidina | |
| GB1322112A (en) | 3,4,5-trimethoxybenzoic acid derivatives and their uses | |
| SE8701592L (sv) | Farmaceutisk komposition som innehaller ett organiskt zinkkomplex samt forfarande for framstellning av den aktiva substansen | |
| JPS6452721A (en) | Diabetic remedy containing 7-thiapprostaglandin e1 as active ingredient | |
| GB739800A (en) | Aqueous pharmaceutical solutions of reserpine for parenteral administration | |
| GB975128A (en) | New anthelmintics | |
| JPS57114512A (en) | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative | |
| GB1174988A (en) | Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same | |
| US3356571A (en) | Potentiation of tetracycline by polyacrylic acid or hydrolyzed polyacrylonitrile | |
| GB1420976A (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
| GB1262315A (en) | New benzenesulphonamide derivatives, their production ond compositions containing same | |
| US3961068A (en) | Use of ipronidazole in combatting Sphaerophorus necrophorus infections | |
| GB1215152A (en) | Biguanide derivatives and pharmaceutical preparations containing them | |
| GB1001314A (en) | Pharmaceutical preparations for combating parasitic helminths | |
| GB1125924A (en) | Organic bismuth derivative | |
| FR2081589A1 (en) | N,n-hexamethylenedithiocarbamates - as hepato protective agents | |
| GB943071A (en) | Pharmaceutical compositions having appetite reducing properties | |
| GB1042490A (en) | Phenoxyalkylaminoguanidines | |
| GB957297A (en) | Pharmaceutical compositions containing oxazoline derivatives |